Evidence map›Paper›PMID 28061972›Full record

ReviewVitamins and hormones2017

Estrogen Receptors Modulation of Anxiety-Like Behavior.

A P Borrow, R J Handa

Abstract readComparative StudyReview
In one paragraph

Review in Vitamins and hormones, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 1 pooled it
34.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 1 synthesis or guideline pooled it, 151 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Common and dissociable effects of oxytocin and lorazepam on the neurocircuitry of fear.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Trial
  4. Article
  5. Article
  6. Multi-ancestry epigenome wide association study of generalized anxiety disorder.medRxiv : the preprint server for health sciences · 2026
    Article
  7. Article
  8. Article
  9. HSPBiomedicines · 2025
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Observational

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

A P BorrowColorado State University, Fort Collins, CO, United States.
R J HandaColorado State University, Fort Collins, CO, United States. Electronic address: bhanda@colostate.edu.
Colorado State University · US

Funding

Estrogen Regulation of the Hypothalamo-Pituitary-Adrenal AxisR01DK105826 · NIDDK · COLORADO STATE UNIVERSITY · PI MYERS, BRENT PHILIP · 2015 to 2020
$2.1M
NIDDK NIH HHS R01 DK105826
6 · The paper itself

Abstract

Estrogens exert profound effects on the expression of anxiety in humans and rodents; however, the directionality of these effects varies considerably within both clinical and preclinical literature. It is believed that discrepancies regarding the nature of estrogens' effects on anxiety are attributable to the differential effects of specific estrogen receptor (ER) subtypes. In this chapter we will discuss the relative impact on anxiety and anxiety-like behavior of each of the three main ERs: ERα, which has a generally anxiogenic effect, ERβ, which has a generally anxiolytic effect, and the G-protein-coupled ER known as GPR30, which has been found to both increase and decrease anxiety-like behavior. In addition, we will describe the known mechanisms by which these receptor subtypes exert their influence on emotional responses, focusing on the hypothalamic-pituitary-adrenal axis and the oxytocinergic and serotonergic systems. The impact of estrogens on the expression of anxiety is likely the result of their combined effects on all of these neurobiological systems.

Indexed as

Active Transport, Cell NucleusAnimalsAnti-Anxiety AgentsAnxietyAnxiety DisordersEstrogen Receptor alphaEstrogen Receptor betaEstrogensHumansHypothalamo-Hypophyseal SystemNerve Tissue ProteinsNeuronsOxytocinPituitary-Adrenal SystemReceptors, EstrogenReceptors, G-Protein-CoupledAnti-Anxiety AgentsESR1 protein, humanESR2 protein, humanEstrogen Receptor alphaEstrogen Receptor betaEstrogensGPER1 protein, humanNerve Tissue ProteinsOXTR protein, humanOxytocinReceptors, EstrogenReceptors, G-Protein-CoupledReceptors, OxytocinAnxietyBetaEstradiolEstrogen receptor alphaGPR30HPAOxytocinSerotonin

Identifiers

PMID28061972
PMCPMC5815294
OpenAlexW2530092364

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.